The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Hormonal contraception refers to birth control methods that act on the endocrine system. Almost all methods are composed of steroid hormones.
The global Hormonal Contraceptive market was valued at US$ 17480 million in 2023 and is anticipated to reach US$ 21910 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.
However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Hormonal Contraceptive, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hormonal Contraceptive.
Report Scope
The Hormonal Contraceptive market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hormonal Contraceptive market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hormonal Contraceptive companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Bayer AG
- Johnson and Johnson
- Mayer Laboratories
- Merck and Co
- Mylan N.V.
- Pfizer
- Teva Pharmaceutical Industries
- The Female Health Company
- Organon International
- Afaxys
Segment by Type
- Oral Contraceptive Pills
- Injectable Birth Control
- Emergency Contraceptive Pills
- Vaginal Rings
- Transdermal Patches
- Others
Segment by Application
- Hospitals
- Household
- Clinics
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hormonal Contraceptive companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hormonal Contraceptive Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral Contraceptive Pills
1.2.3 Injectable Birth Control
1.2.4 Emergency Contraceptive Pills
1.2.5 Vaginal Rings
1.2.6 Transdermal Patches
1.2.7 Others
1.3 Market by Application
1.3.1 Global Hormonal Contraceptive Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Household
1.3.4 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hormonal Contraceptive Market Perspective (2019-2030)
2.2 Hormonal Contraceptive Growth Trends by Region
2.2.1 Global Hormonal Contraceptive Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hormonal Contraceptive Historic Market Size by Region (2019-2024)
2.2.3 Hormonal Contraceptive Forecasted Market Size by Region (2025-2030)
2.3 Hormonal Contraceptive Market Dynamics
2.3.1 Hormonal Contraceptive Industry Trends
2.3.2 Hormonal Contraceptive Market Drivers
2.3.3 Hormonal Contraceptive Market Challenges
2.3.4 Hormonal Contraceptive Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hormonal Contraceptive Players by Revenue
3.1.1 Global Top Hormonal Contraceptive Players by Revenue (2019-2024)
3.1.2 Global Hormonal Contraceptive Revenue Market Share by Players (2019-2024)
3.2 Global Hormonal Contraceptive Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hormonal Contraceptive Revenue
3.4 Global Hormonal Contraceptive Market Concentration Ratio
3.4.1 Global Hormonal Contraceptive Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hormonal Contraceptive Revenue in 2023
3.5 Hormonal Contraceptive Key Players Head office and Area Served
3.6 Key Players Hormonal Contraceptive Product Solution and Service
3.7 Date of Enter into Hormonal Contraceptive Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hormonal Contraceptive Breakdown Data by Type
4.1 Global Hormonal Contraceptive Historic Market Size by Type (2019-2024)
4.2 Global Hormonal Contraceptive Forecasted Market Size by Type (2025-2030)
5 Hormonal Contraceptive Breakdown Data by Application
5.1 Global Hormonal Contraceptive Historic Market Size by Application (2019-2024)
5.2 Global Hormonal Contraceptive Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hormonal Contraceptive Market Size (2019-2030)
6.2 North America Hormonal Contraceptive Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hormonal Contraceptive Market Size by Country (2019-2024)
6.4 North America Hormonal Contraceptive Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hormonal Contraceptive Market Size (2019-2030)
7.2 Europe Hormonal Contraceptive Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hormonal Contraceptive Market Size by Country (2019-2024)
7.4 Europe Hormonal Contraceptive Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hormonal Contraceptive Market Size (2019-2030)
8.2 Asia-Pacific Hormonal Contraceptive Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hormonal Contraceptive Market Size by Region (2019-2024)
8.4 Asia-Pacific Hormonal Contraceptive Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hormonal Contraceptive Market Size (2019-2030)
9.2 Latin America Hormonal Contraceptive Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hormonal Contraceptive Market Size by Country (2019-2024)
9.4 Latin America Hormonal Contraceptive Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hormonal Contraceptive Market Size (2019-2030)
10.2 Middle East & Africa Hormonal Contraceptive Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hormonal Contraceptive Market Size by Country (2019-2024)
10.4 Middle East & Africa Hormonal Contraceptive Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Detail
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Hormonal Contraceptive Introduction
11.1.4 Bayer AG Revenue in Hormonal Contraceptive Business (2019-2024)
11.1.5 Bayer AG Recent Development
11.2 Johnson and Johnson
11.2.1 Johnson and Johnson Company Detail
11.2.2 Johnson and Johnson Business Overview
11.2.3 Johnson and Johnson Hormonal Contraceptive Introduction
11.2.4 Johnson and Johnson Revenue in Hormonal Contraceptive Business (2019-2024)
11.2.5 Johnson and Johnson Recent Development
11.3 Mayer Laboratories
11.3.1 Mayer Laboratories Company Detail
11.3.2 Mayer Laboratories Business Overview
11.3.3 Mayer Laboratories Hormonal Contraceptive Introduction
11.3.4 Mayer Laboratories Revenue in Hormonal Contraceptive Business (2019-2024)
11.3.5 Mayer Laboratories Recent Development
11.4 Merck and Co
11.4.1 Merck and Co Company Detail
11.4.2 Merck and Co Business Overview
11.4.3 Merck and Co Hormonal Contraceptive Introduction
11.4.4 Merck and Co Revenue in Hormonal Contraceptive Business (2019-2024)
11.4.5 Merck and Co Recent Development
11.5 Mylan N.V.
11.5.1 Mylan N.V. Company Detail
11.5.2 Mylan N.V. Business Overview
11.5.3 Mylan N.V. Hormonal Contraceptive Introduction
11.5.4 Mylan N.V. Revenue in Hormonal Contraceptive Business (2019-2024)
11.5.5 Mylan N.V. Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Hormonal Contraceptive Introduction
11.6.4 Pfizer Revenue in Hormonal Contraceptive Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Company Detail
11.7.2 Teva Pharmaceutical Industries Business Overview
11.7.3 Teva Pharmaceutical Industries Hormonal Contraceptive Introduction
11.7.4 Teva Pharmaceutical Industries Revenue in Hormonal Contraceptive Business (2019-2024)
11.7.5 Teva Pharmaceutical Industries Recent Development
11.8 The Female Health Company
11.8.1 The Female Health Company Company Detail
11.8.2 The Female Health Company Business Overview
11.8.3 The Female Health Company Hormonal Contraceptive Introduction
11.8.4 The Female Health Company Revenue in Hormonal Contraceptive Business (2019-2024)
11.8.5 The Female Health Company Recent Development
11.9 Organon International
11.9.1 Organon International Company Detail
11.9.2 Organon International Business Overview
11.9.3 Organon International Hormonal Contraceptive Introduction
11.9.4 Organon International Revenue in Hormonal Contraceptive Business (2019-2024)
11.9.5 Organon International Recent Development
11.10 Afaxys
11.10.1 Afaxys Company Detail
11.10.2 Afaxys Business Overview
11.10.3 Afaxys Hormonal Contraceptive Introduction
11.10.4 Afaxys Revenue in Hormonal Contraceptive Business (2019-2024)
11.10.5 Afaxys Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
